This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Project is part of a contract project with Merck Frosst Centre for Respiratory Imaging, Robarts Research Institute, Ontario, CanadaThe primary aim is to clearly demonstrate the ability of 3He imaging to differentiate the airway hyper-responsiveness (AHR) phenotype in several mouse models of asthma as specified by Merck. Various image analysis and quantification paradigms will be tested. An initial aim is to integrate Merck's specialized 3He ventilator with the imaging. The project is thus broken down into three stages and associated milestones. -- Stage I is to test the performance of the Merck ventilator against the Duke ventilator for hyperpolarized 3He delivery and imaging. -- Simultaneously, the Merck asthma model will be implemented and evaluated at Duke in the laboratory of Dr. Mike Foster. -- Once a suitable ventilator is chosen, Stage II will employ 3He imaging to test differences in AHR between an OVA/PBS mouse and an OVA/OVA mouse.
Showing the most recent 10 out of 239 publications